Literature DB >> 8037655

Expression of the Wilson disease gene is deficient in the Long-Evans Cinnamon rat.

Y Yamaguchi1, M E Heiny, N Shimizu, T Aoki, J D Gitlin.   

Abstract

Long-Evans Cinnamon rats develop a necrotizing hepatitis characterized by excessive hepatic copper accumulation, defective holoceruloplasmin biosynthesis and impaired biliary copper excretion. To elucidate the molecular basis of this defect, a cDNA clone encoding the rat Wilson disease gene was isolated and used to examine gene expression in selected tissues from normal and Long-Evans Cinnamon rats. Although this cDNA readily detects Wilson transcripts in liver and other tissues from normal rats, such transcripts are entirely absent from tissues derived from the Long-Evans Cinnamon rat strain. These data therefore identify the Long-Evans Cinnamon rat as the first bona fide animal model of Wilson disease and suggest that this rat strain may be a valuable resource in the study of this genetic disorder.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8037655      PMCID: PMC1137132          DOI: 10.1042/bj3010001

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

Review 1.  Perspectives on Wilson's disease.

Authors:  I Sternlieb
Journal:  Hepatology       Date:  1990-11       Impact factor: 17.425

2.  Mechanisms of copper incorporation during the biosynthesis of human ceruloplasmin.

Authors:  M Sato; J D Gitlin
Journal:  J Biol Chem       Date:  1991-03-15       Impact factor: 5.157

3.  Primary structure of rat ceruloplasmin and analysis of tissue-specific gene expression during development.

Authors:  R E Fleming; J D Gitlin
Journal:  J Biol Chem       Date:  1990-05-05       Impact factor: 5.157

Review 4.  Of mice and men, metals and mutations.

Authors:  D M Danks
Journal:  J Med Genet       Date:  1986-04       Impact factor: 6.318

5.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

6.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

7.  A genetical analysis of thirty families with Wilson's disease (hepatolenticular degeneration).

Authors:  A G BEARN
Journal:  Ann Hum Genet       Date:  1960-04       Impact factor: 1.670

8.  New mutation causing hereditary hepatitis in the laboratory rat.

Authors:  M C Yoshida; R Masuda; M Sasaki; N Takeichi; H Kobayashi; K Dempo; M Mori
Journal:  J Hered       Date:  1987 Nov-Dec       Impact factor: 2.645

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  High susceptibility to hepatocellular carcinoma development in LEC rats with hereditary hepatitis.

Authors:  R Masuda; M C Yoshida; M Sasaki; K Dempo; M Mori
Journal:  Jpn J Cancer Res       Date:  1988-07
View more
  6 in total

Review 1.  ACP Best Practice No 163. Wilson's disease: acute and presymptomatic laboratory diagnosis and monitoring.

Authors:  D Gaffney; G S Fell; D S O'Reilly
Journal:  J Clin Pathol       Date:  2000-11       Impact factor: 3.411

Review 2.  Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes.

Authors:  P de Bie; P Muller; C Wijmenga; L W J Klomp
Journal:  J Med Genet       Date:  2007-08-23       Impact factor: 6.318

3.  Functional expression of the Wilson disease protein reveals mislocalization and impaired copper-dependent trafficking of the common H1069Q mutation.

Authors:  A S Payne; E J Kelly; J D Gitlin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

4.  Aceruloplasminemia: molecular characterization of this disorder of iron metabolism.

Authors:  Z L Harris; Y Takahashi; H Miyajima; M Serizawa; R T MacGillivray; J D Gitlin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

5.  A novel rat model of hereditary hemochromatosis due to a mutation in transferrin receptor 2.

Authors:  Thomas B Bartnikas; Sheryl J Wildt; Amy E Wineinger; Klaus Schmitz-Abe; Kyriacos Markianos; Dale M Cooper; Mark D Fleming
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

6.  Simultaneous monitoring of cerebral metal accumulation in an experimental model of Wilson's disease by laser ablation inductively coupled plasma mass spectrometry.

Authors:  Sorina Georgiana Boaru; Uta Merle; Ricarda Uerlings; Astrid Zimmermann; Sabine Weiskirchen; Andreas Matusch; Wolfgang Stremmel; Ralf Weiskirchen
Journal:  BMC Neurosci       Date:  2014-08-20       Impact factor: 3.288

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.